MMarkets Read More Sleep Aids Market to Hit US$ 118.97 Billion by 2033, Growing at 7.8% CAGR19 September 2025 AUSTIN, Texas and TOKYO, Sept. 19, 2025 /PRNewswire/ — According to DataM Intelligence, the global sleep aids market…
MMarkets Read More Global Minimal Residual Disease Testing Market Gearing Up for Outstanding Expansion at a CAGR of ~11% by 203220 August 2025 The demand for minimal residual disease testing is increasing mainly due to the higher prevalence of solid tumors…
MMarkets Read More Medical Coating Market worth $15,813.6 million by 203022 July 2025 DELRAY BEACH, Fla., July 22, 2025 /PRNewswire/ — The report “ Medical Coatings Market by Coating Type (Active, Passive), By Material…
MMarkets Read More SERM Market Shows Promising Growth Trajectory During the Study Period (2020-2034) Owing to the Rising Demand in Oncology and Women’s Health17 July 2025 The SERMs market is projected to experience substantial growth in the near future, driven by a rising incidence…
MMarkets Read More Spine Degenerative Disk Disease Treatment Market to Reach USD 39,589.9 Billion by 2032, Growing at a CAGR of 4.39%: Credence Research9 July 2025 PUNE, India, July 9, 2025 /PRNewswire/ — According to Credence Research, the global Spine Degenerative Disk Disease Treatment…
MMarkets Read More Tooth Replacement Market to Reach $30.6 Billion by 2032, Growing at a CAGR of 7.7% from 2025, Says Meticulous Research®25 June 2025 Market Growth Driven by High Prevalence of Dental Caries & Edentulism, Rising Cosmetic Dentistry Demand, Digital Technology Adoption,…
HHealthcare Read More Illumina and Ovation.io launching first-of-kind GLP-1 dataset to accelerate new therapy development3 May 2025 First real-world dataset with integrated clinical and multiomic insights from 25,000 patients treated with GLP-1 therapies Dataset will…
GGenetics Read More CellFE® Partners with DKFZ and TcellTech to Advance DNA Vector Genetic Engineering for Cellular Therapies3 May 2025 ALAMEDA, Calif., April 30, 2025 /PRNewswire/ — CellFE, a leader in non-viral gene editing technology, today announced a…
HHealthcare Read More Novo Nordisk announces that CVS Caremark®, the country’s largest PBM, has decided Wegovy® will be the preferred GLP-1 medicine covered for obesity on its template formularies2 May 2025 Wegovy® will be the preferred GLP-1 medicine for obesity on the largest commercial template formularies for CVS Caremark,…
MMarkets Read More Image-guided Navigation Market worth US$3,912.5 million by 2030 with 9.0% CAGR1 May 2025 DELRAY BEACH, Fla., May 1, 2025 /PRNewswire/ — The global Image-guided Navigation Market, valued at US$2,335.5 million in 2024,…